Southwest Florida Research
Naples, Florida, United States
Research institute in Naples, Florida
625 9th St N Suite 202, Naples, FL 34102
About Southwest Florida Research
"Southwest Florida Research (SWFR) is a research center of excellence for the administration of Phase II-IV clinical trials in pharmaceutical and medical devices. We also operate as a healthcare business incubator and market research firm dedicated to researching and sponsoring innovation in healthcare delivery."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Bayer
5
Pfizer
2
Amgen
1
Boehringer Ingelheim
1
Brigham and Women's Hospital
1
Eisai Inc.
1
Tasly Pharmaceuticals, Inc.
1
Vifor (International) Inc.
1
Clinical Trials at Southwest Florida Research
During the past decade, Southwest Florida Research conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 8 clinical trials were completed, i.e. on
average, 88.9% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors
2014-01-24
2018-05-14
Completed
14,673
Uninterrupted Dabigatran Etexilate in Comparison to Uninterrupted Warfarin in Pulmonary Vein Ablation (RE-CIRCUIT)
2015-04-28
2016-11-14
Completed
678
A Trial to Study Neladenoson Bialanate Over 20 Weeks in Patients With Chronic Heart Failure With Reduced Ejection Fraction
2017-02-22
2018-05-16
Completed
427
Patient-reported Outcomes in Vericiguat-treated Patients With HFpEF
2018-06-15
2019-11-04
Completed
789
Outcome Research to Confirm the Anti-anginal Effect of T89 in Patients With Stable Angina
2019-08-01
2023-09-01
Recruiting
765
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Southwest Florida Research" #1 sponsor was "Bayer" with 5 trials, followed by "Pfizer" with 2 trials
sponsored, "Amgen" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Brigham and Women's Hospital"
with 1 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Southwest Florida Research"
#1 collaborator was "Duke Clinical Research Institute" with 2 trials as a collaborator, "Canadian VIGOUR Centre" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "Thrombolysis In Myocardial Infarction (TIMI) Academic Research Organization" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at Southwest Florida Research
According to Clinical.Site data, the most researched conditions in "Southwest Florida Research" are
"Cardiovascular Disease" (4 trials), "Heart Failure" (3 trials), "Atrial Fibrillation" (2 trials), "ASCVD" (1 trials) and "Acute Myocardial Infarction" (1 trials). Many other conditions were trialed in "Southwest Florida Research" in a lesser frequency.
Clinical Trials Intervention Types at Southwest Florida Research
Most popular intervention types in "Southwest Florida Research" are "Drug" (11 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "bococizumab (PF-04950615)" (2 trials), "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials) and "Asundexian (BAY2433334)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Southwest Florida Research
The vast majority of trials in "Southwest Florida Research" are
13 trials for "All" genders.
Clinical Trials Status at Southwest Florida Research
Currently, there are NaN active trials in "Southwest Florida Research".
undefined are not yet recruiting,
3 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Southwest Florida Research,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Southwest Florida Research, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".